American Shared Hospital Services  

(Public, NYSEMKT:AMS)   Watch this stock  
Find more results for NYSEAMEX:AMS
2.84
-0.04 (-1.39%)
Real-time:   10:22AM EDT
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 2.79 - 2.89
52 week 1.52 - 3.46
Open 2.80
Vol / Avg. 2,001.00/16,018.00
Mkt cap 13.09M
P/E     -
Div/yield     -
EPS -0.05
Shares 4.61M
Beta 0.60
Inst. own 9%
Mar 31, 2014
Q4 2013 American Shared Hospital Services Earnings Release (Estimated)
Mar 27, 2014
Q4 2013 American Shared Hospital Services Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin -3.03% 4.77%
Operating margin 3.69% 4.28%
EBITD margin - 52.68%
Return on average assets -0.73% 1.10%
Return on average equity -2.72% 0.19%
Employees 10 -
CDP Score - -

Address

FOUR EMBARCADERO CENTER, SUITE 3700
SAN FRANCISCO, CA 94111-4107
United States - Map
+1-415-7885300 (Phone)
+1-415-7885660 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

American Shared Hospital Services (ASHS) provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to 19 medical centers in 16 states in the United States and Turkey, as of March 1, 2012. It provides Gamma Knife services through its 81% indirect interest in GK Financing, LLC (GKF). The remaining 19% of GKF is owned by GKV Investments, Inc., which is a wholly owned United States subsidiary of Elekta AG (Elekta). Elekta is the manufacturer of the Leksell Gamma Knifea (the Gamma Knife). GKF is a non-exclusive provider of alternative financing services for Elekta Gamma Knife units. Gamma Knife revenue accounted for 95% of the Company�s revenue, during the year ended December 31, 2011. It also provides Image Guided Radiation Therapy (IGRT) and related equipment to two medical centers located in Massachusetts and Turkey which accounted for 5% of the Company�s revenue, during 2011.

Officers and directors

Ernest A. Bates M.D. Chairman of the Board, Chief Executive Officer
Age: 76
Bio & Compensation  - Reuters
Craig K. Tagawa Senior Vice President, Chief Operating Officer, Chief Financial Officer
Age: 59
Bio & Compensation  - Reuters
Ernest R. Bates Vice President - Sales and Business Development
Age: 46
Bio & Compensation  - Reuters
John F. Ruffle Lead Independent Director
Age: 76
Bio & Compensation  - Reuters
S. Mert Ozyurek Director
Age: 38
Bio & Compensation  - Reuters
David A. Larson M.D., Ph.D. Independent Director
Age: 72
Bio & Compensation  - Reuters
Raymond C. Stachowiak Independent Director
Age: 55
Bio & Compensation  - Reuters
Stanley S. Trotman Jr. Independent Director
Age: 70
Bio & Compensation  - Reuters